Evidence map›Paper›PMID 34924815›Full record

ArticleMediators of inflammation2021

Butyrate Inhibits Osteoclast Activity

Alexandra Wallimann, Walker Magrath, Brenna Pugliese, Nino Stocker, Patrick Westermann, Anja Heider, Dominic Gehweiler, Stephan Zeiter, Marcus J Claesson, R Geoff Richards and 5 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Mediators of inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Microbiology spectrum · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Alexandra WallimannAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0001-6755-3679
Walker MagrathAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0001-8576-1156
Brenna PuglieseAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0003-1636-2439
Nino StockerSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-3200-8982
Patrick WestermannSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-2894-6140
Anja HeiderSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Dominic GehweilerAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0001-7148-9569
Stephan ZeiterAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0002-8155-4202
Marcus J ClaessonSeqBiome Ltd., 3 Castleheights, Bandon, County Cork, Ireland.ORCID https://orcid.org/0000-0002-5712-0623
R Geoff RichardsAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0002-7778-2480
Cezmi A AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-8020-019X
Christopher J HernandezSibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, USA.ORCID https://orcid.org/0000-0002-0712-6533
Liam O'MahonyDepartments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, College Road, Cork, Ireland.ORCID https://orcid.org/0000-0003-4705-3583
Keith ThompsonAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0002-9167-5147
T Fintan MoriartyAO Research Institute Davos, Davos, Switzerland.ORCID https://orcid.org/0000-0003-2307-0397
AO Foundation · CHUniversity of Zurich · CHBon Secours Hospital Cork · IEHospital for Special Surgery · USUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short-chain fatty acids (SCFAs) produced by the gut microbiota have previously been demonstrated to play a role in numerous chronic inflammatory diseases and to be key mediators in the gut-bone signaling axis. However, the role of SCFAs in bone fracture healing and its impact on systemic inflammation during the regeneration process has not been extensively investigated yet. The aim of this study was to first determine the effects of the SCFA butyrate on key cells involved in fracture healing

Indexed as

AnimalsAnti-Bacterial AgentsButyratesCell DifferentiationCells, CulturedCytokinesFatty Acids, VolatileFracture HealingGastrointestinal MicrobiomeHumansInflammationInflammation MediatorsLevofloxacinMaleMiceMice, Inbred C57BLAnti-Bacterial AgentsButyratesCytokinesFatty Acids, VolatileInflammation MediatorsLevofloxacinRifampin

Identifiers

PMID34924815
PMCPMC8683197
OpenAlexW4200023607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.